Dear Colleagues, dear Friends,
On behalf of the European Association of Nuclear Medicine, it is my great pleasure and honour to cordially invite you to the 32nd Annual EANM Congress in October 2019. This year, our congress will take place in Barcelona, Spain. The city is world famous for its hospitality, its cultural attractions and its culinary highlights.
Molecular imaging is continuously expanding: it is increasingly being combined with advanced technologies such as artificial intelligence and has become a principal component of medical imaging. In the therapy field, targeted radiopharmaceuticals have been demonstrated to be effective and are increasingly used in a variety of clinical settings, often integrated with other therapeutic options. The ultimate goal is to design personalised, super-selective therapies and to identify more precise means of monitoring response to treatment in routine clinical practice.
In the last three years, the status of the EANM annual meeting as the world-reference congress in nuclear medicine has been confirmed. In order to maintain the high level of excellence, the 2019 EANM Congress will build on the traditions that are highly appreciated by all attendees, with the expansion of newer features. A specific educational track, implemented with the collaboration of the European School of Multimodality Imaging and Therapy, will include up-to-date teaching sessions, enriched pitfalls seminars and Continuous Medical Education interactive sessions. In all these active learning conferences, attendees will have the possibility to enhance their knowledge of multimodality imaging. A careful evaluation procedure relating to the speakers will be implemented in order to gain feedback and ensure that future interactive sessions continue to enjoy a positive response. With similar pedagogic intent, numerous multidisciplinary joint symposia, organised by several EANM Committees in collaboration with our sister societies, will offer an integrative approach to various topics relevant to the state of the art of our discipline.
All these learning sessions will not impact adversely on the predominant role of our Congress, which is to enable oral and electronic poster presentations on the latest achievements in clinical nuclear medicine, science and technology. On the contrary, the oral sessions will be enriched. Rapid Fire sessions will draw attention to the highly rated abstracts in specific fields, with a panel of top-level presentations followed by extensive discussions; this will provide attendees with an integrated and coherent view on a wide variety of topics. Furthermore, the concept of featured oral sessions in which an invited speaker places the presentations into a broader perspective will be generalised to all the other oral presentations. The now well-established tracks M2M – Molecule to Man (basic and translational science) and Do.MoRe (radionuclide therapy and dosimetry) promise to promote high-quality research through interaction between basic and translational clinical scientists and to present the latest achievements and developments in the fields of clinical molecular imaging and nuclear medicine therapy.
During plenary lectures, distinguished speakers will address the state of the art and new developments in clinical and allied sciences, covering a broad range of topics with the goal of fostering the provision of the best possible care for our patients. I am particularly delighted that two young but very motivated and highly respected members of our European Nuclear Medicine community, Dr. Valentina Garibotto from Geneva, Switzerland, and Dr. Sarah Schwarzenböck from Rostock, Germany, will provide the traditional Highlights lecture.
For all these reasons, I cordially invite you to EANM’19 to actively participate in our 32nd Annual Congress, to meet and interact with friends and colleagues from all over the world, to discuss science, to learn about the exciting developments in nuclear medicine, to break away from the daily routine and to enjoy everything that the city of Barcelona has to offer.
EANM Congress Chair 2017–2019